SRPT Sarepta Therapeutics

Healthcare Biotechnology

Latest news and analysis for Sarepta Therapeutics (SRPT).

1 article | Category: Healthcare

Current Price

$16.76 -0.69 (-3.95%)

Market data may be delayed

Price Chart

Loading chart...

All Articles for SRPT

Healthcare | SRPT | 8h ago

Sarepta Therapeutics: Price Target Cut Signals Shift Ahead

Sarepta Therapeutics sees its price target reduced to $38 by Wells Fargo, while still holding an Overweight rating. What does this mean for SRPT investors?

Related Stocks in Healthcare

LLY

Eli Lilly 6 articles

PFE

Pfizer Inc. 3 articles

VRTX

Vertex Pharmaceuticals 3 articles

RARE

Ultragenyx Pharmaceutical 3 articles

NVO

Novo Nordisk 3 articles

HIMS

Hims & Hers Health 3 articles

JNJ

Johnson & Johnson 2 articles

GILD

Gilead Sciences 2 articles

SYK

Stryker Corp. 2 articles

REGN

Regeneron Pharmaceuticals 2 articles

ELV

Elevance Health 2 articles

HUM

Humana Inc. 2 articles

Cookie Notice

SRPT Sarepta Therapeutics

Price Chart

All Articles for SRPT

Sarepta Therapeutics: Price Target Cut Signals Shift Ahead

Related Stocks in Healthcare